Search Results - "Le Guillou, Dounia"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages by Groeger, Marko, Matsuo, Koji, Heidary Arash, Emad, Pereira, Ashley, Le Guillou, Dounia, Pino, Cindy, Telles-Silva, Kayque A., Maher, Jacquelyn J., Hsiao, Edward C., Willenbring, Holger

    Published in Nature communications (03-07-2023)
    “…Hepatic insulin resistance is recognized as a driver of type 2 diabetes and fatty liver disease but specific therapies are lacking. Here we explore the…”
    Get full text
    Journal Article
  5. 5

    The Role of STING in Liver Injury Is Both Stimulus- and Time-Dependent by Siao, Kevin, Le Guillou, Dounia, Maher, Jacquelyn J, Duwaerts, Caroline C

    Published in Nutrients (28-09-2022)
    “…STING, Tmem173, is involved in liver injury caused by both infectious and sterile inflammatory models. Its role in toxic liver injury and non-alcoholic fatty…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Bisphenol a induces steatosis in HepaRG cells using a model of perinatal exposure by Bucher, Simon, Jalili, Pégah, Le Guillou, Dounia, Begriche, Karima, Rondel, Karine, Martinais, Sophie, Zalko, Daniel, Corlu, Anne, Robin, Marie‐Anne, Fromenty, Bernard

    Published in Environmental toxicology (01-03-2017)
    “…ABSTRACT Human exposure to bisphenol A (BPA) could favor obesity and related metabolic disorders such as hepatic steatosis. Investigations in rodents have…”
    Get full text
    Journal Article
  9. 9

    Chronic exposure to low doses of pharmaceuticals disturbs the hepatic expression of circadian genes in lean and obese mice by Anthérieu, Sébastien, Le Guillou, Dounia, Coulouarn, Cédric, Begriche, Karima, Trak-Smayra, Viviane, Martinais, Sophie, Porceddu, Mathieu, Robin, Marie-Anne, Fromenty, Bernard

    Published in Toxicology and applied pharmacology (01-04-2014)
    “…Drinking water can be contaminated with pharmaceuticals. However, it is uncertain whether this contamination can be harmful for the liver, especially during…”
    Get full text
    Journal Article
  10. 10

    Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis by Sharma, Sachin, Le Guillou, Dounia, Chen, Jennifer Y.

    “…The burden of chronic liver disease is rising substantially worldwide. Fibrosis, characterized by excessive deposition of extracellular matrix proteins, is the…”
    Get full text
    Journal Article
  11. 11

    Drug-induced liver injury in obesity and nonalcoholic fatty liver disease by Allard, Julien, Le Guillou, Dounia, Begriche, Karima, Fromenty, Bernard

    Published in Advances in pharmacology (1990) (2019)
    “…Obesity is commonly associated with nonalcoholic fatty liver (NAFL), a benign condition characterized by hepatic lipid accumulation. However, NAFL can progress…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19